Research Insight

Immuneering Corporation Expands Alliance with Bristol-Myers Squibb

Immuneering Corporation announced today that it has entered into an agreement to expand its existing relationship with Bristol-Myers Squibb for the use...

IMI Builds Collaborations to Monitor Vaccine Safety and Drug...

The Innovative Medicines Initiative (IMI) is calling experts to join forces and tackle two challenges which are of major importance to public health. ...

Warfarin and aspirin are similar in heart failure treatment

In the largest and longest head-to-head comparison of two anti-clotting medications, warfarin and aspirin were similar in preventing deaths and strokes in heart failure patients...

Researchers Refine Nanoparticles For More Accurate Delivery Of Cancer...

A new class of nanoparticles, synthesized by a UC Davis research team to prevent premature drug release, holds promise for greater accuracy and effectiveness...

Mylan introduces new antiepileptic drug

Mylan Institutional business has launched Levetiracetam in Sodium Chloride Injection of multiple strengths, 500mg/100ml, 1000mg/100ml and 1500mg/100ml, for intravenous use. ...

Vidacare study reveals IO infusion equivalent to IV in...

Vidacare's study to compare Intraosseous (IO) vascular access to infuse chilled saline as effectively as peripheral intravenous (IV) access to achieve therapeutic hypothermia showed no...

New data confirm the benefits of early and first...

Bayer HealthCare announced that researchers have presented data from two international long-term follow-up studies in multiple sclerosis: the BENEFIT (BEtaferon in Newly Emerging multiple sclerosis...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read